'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption

Colloids and Surfaces B: Biointerfaces

Volumn 18, Issue 3-4, 2000, Pages 301-313

  Gref, R ^a   Luck M ^b   Quellec, P ^c   Marchand, M ^d   Dellacherie, E ^c   Harnisch, S ^b   Blunk, T ^e   Muller R H ^b  

^a Pharmacotech Biopharm UMR C   (France)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c LAB DE CHIM PHYS MACROMOLECULAIRE   (France)

^d Etablissement de Transfus Sanguine   (France)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

'Stealth' nanoparticles; Biodegradable copolymer; Phagocytosis; Plasma proteins; Polyethylene glycol

Indexed keywords

COPOLYMER; MACROGOL; NANOPARTICLE;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; DRUG DESIGN; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; SURFACE PROPERTY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 0343191443     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0927-7765(99)00156-3     Document Type: Article

References (44)

1. J. Kreuter, in: J. Kreuter (Ed.), Colloidal Drug Delivery Systems. Marcel Dekker, New York 1994, 219-315.
2. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. FEBS Lett. 268:1990;235-237.
3. Storm G., Belliot S.O., Daemen T., Lasic D.D. Adv. Drug Deliv. Rev. 17:1995;31-48.
4. Illum L., Davis S.S., Müller R.H., Mak E., West P. Life Sci. 40:1987;367-374.
5. Müller R.H. Colloidal Carriers for Controlled Drug Delivery and Targeting. 1991;CRC Press, Boca Raton.
6. Gombotz W.R., Guanghui W., Horbett T.A., Hoffman A.S. J. Biomed. Mater. Res. 25:1991;1547-1562.
7. Neal J.C., Stolnik S., Schacht E. et al. J. Pharm. Sci. 87:1998;1242-1248.
8. Gref R., Domb A., Quellec P. et al. Adv. Drug Deliv. Rev. 16:1995;215-233.
9. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Science. 263:1994;1600-1603.
10. Verecchia T., Spenlehauer G., Bazile D.V., Murry-Brelier A., Archimbaud Y., Veillard M. J. Control. Rel. 36:1995;49-61.
11. Bazile D., Prud'homme C., Bassoullet M.T., Marlard M., Spenlehauer G., Veillard M. J. Pharm. Sci. 84:1995;493-498.
12. Vittaz M., Bazile D., Spenlehauer G. et al. Biomaterials. 17:1996;1575-1581.
13. Dunn S.E., Stolnik S., Garnett M.C. et al. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 21:1994;210-211.
14. Stolnik S., Dunn S.E., Garnett M.C. et al. Pharm. Res. 11:1994;1800-1808.
15. Labarre D., Vittaz M., Spenlehauer G., Bazile D., Veillard M. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 21:1994;91-92.
16. Hrkach J.S., Peracchia M.T., Domb A., Lotan N., Langer R. Biomaterials. 18:1997;27-30.
17. Juliano R.L. Adv. Drug Deliv. Rev. 2:1988;31-54.
18. R.H. Müller, S. Heinemann, in: R. Gurny, H.E. Junginger (Eds.), Bioadhesion - Possibilities and Future Trends. Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1989, 202-213.
19. Patel H.M. Crit. Rev. Ther. Drug Carr. Syst. 9:1992;39-90.
20. Stolnik S., Illum L., Davis S.S. Adv. Drug Deliv. Rev. 16:1995;195-215.
21. Leroux J.-C., Allémann E., De Jaeghere F., Doelker E., Gurny R. J. Control. Rel. 39:1996;339-350.
22. Leroux J.-C., Gravel P., Balant L. et al. J. Biomed. Mater. Res. 28:1994;471-481.
23. Blunk T., Hochstrasser D.F., Sanchez J.-C., Müller B.W., Müller R.H. Electrophoresis. 14:1993;1382-1387.
24. Sahli H., Tapon-Bretaudiere J., Fischer A.M. et al. Biomaterials. 18:1997;281-288.
25. Jeon S.I., Andrade J.D. J. Colloid Interf. Sci. 142:1991;159-166.
26. Jeon S.I., Lee J.H., Andrade J.D., De Gennes P.G. J. Colloid Interf. Sci. 142:1991;149-158.
27. Stossel T.P., Mason R.J., Hartwig J., Vaughan M. J. Clin. Invest. 51:1972;615-624.
28. Rudt S., Müller R.H. J. Control. Rel. 22:1992;263-272.
29. Rudt S., Müller R.H. J. Control. Rel. 25:1993;51-59.
30. Yasukawa S., Oshima H., Muramatsu N., Kondo T. J. Microencaps. 7:1990;179-184.
31. Quellec P., Gref R., Perrin L. et al. J. Biomed. Mater. Res. 42/1:1998;45-54.
32. P. Quellec, Nanospheres "furtives" à base de copolymeres biodégradables pour la libération contrôlée de principes actifs hydrophobes et de protéines, Ph.D thesis, INPL, Nancy, France (1997).
33. Hochstrasser D.F., Harrington M.G., Hochstrasser A.-C., Miller M.J., Merril C.R. Anal. Biochem. 173:1988;424-435.
34. Blunk T., Lück M., Calvör A. et al. Eur. J. Pharm. Biopharm. 42:1996;262-268.
35. Appel R.D., Hochstrasser D.F., Funk M. et al. Electrophoresis. 12:1991;722-735.
36. Dunn M.J., Burghes A.H.M. Electrophoresis. 4:1983;173-189.
37. Golaz O., Hughes G.J., Frutiger S. et al. Electrophoresis. 14:1993;1223-1231.
38. Lück M., Schröder W., Harnisch S. et al. Electrophoresis. 18:1997;2961-2967.
39. Bergström K., Holmberg K., Safranj A. et al. J. Biomed. Mater. Res. 26:1992;779-790.
40. Bergström K., Österberg E., Holmberg K. et al. J. Biomater. Sci. Polymer Edn. 6:1994;123-132.
41. Szleifer I. Biophys. J. 72:1997;595-612.
42. Gref R., Miralles G., Dellacherie E. Polymer Int. 48:1999;251-256.
43. Scieszka J., Cho M. Pharmacol. Res. 5:1988;352-358.
44. Muir I., Moghimi S., Illum L., Davis S., Davies M. Biochem. Soc. Trans. 19:1991;329S.